122 related articles for article (PubMed ID: 8543732)
1. Ciprofloxacin desensitization in a patient with cystic fibrosis.
Lantner RR
J Allergy Clin Immunol; 1995 Dec; 96(6 Pt 1):1001-2. PubMed ID: 8543732
[No Abstract] [Full Text] [Related]
2. Oral "desensitization" of maculopapular exanthema from ciprofloxacin.
Bircher AJ; Rutishauser M
Allergy; 1997 Dec; 52(12):1246-8. PubMed ID: 9450149
[No Abstract] [Full Text] [Related]
3. A revision of rapid colistin desensitization.
Rigg L; Wu SS; Hull D; Hostoffer RW
Ann Allergy Asthma Immunol; 2019 Dec; 123(6):607-608. PubMed ID: 31542505
[No Abstract] [Full Text] [Related]
4. Anaphylactic reaction to ciprofloxacin in a toddler: successful desensitization.
Erdem G; Staat MA; Connelly BL; Assa'ad A
Pediatr Infect Dis J; 1999 Jun; 18(6):563-4. PubMed ID: 10391195
[No Abstract] [Full Text] [Related]
5. Continuous intravenous β-lactam antibiotics in cystic fibrosis patients with severe drug hypersensitivity.
Breuer O; Cohen-Cymberknoh M; Armoni S; Kerem E; Shoseyov D
Ann Allergy Asthma Immunol; 2014 Aug; 113(2):229-30. PubMed ID: 24934107
[No Abstract] [Full Text] [Related]
6. Anaphylactic shock secondary to oral ofloxacin administration with cross-reactivity to levofloxacin and ciprofloxacin.
Ouni B; Fathallah N; Slim R; Brahim A; Ben Salem C
Therapie; 2018 Dec; 73(6):555-556. PubMed ID: 30401472
[No Abstract] [Full Text] [Related]
7. Intravenous desensitization to ceftazidime in cystic fibrosis patients.
Ghosal S; Taylor CJ
J Antimicrob Chemother; 1997 Apr; 39(4):556-7. PubMed ID: 9145836
[No Abstract] [Full Text] [Related]
8. Ciprofloxacin desensitization.
Gea-Banacloche JC; Metcalfe DD
J Allergy Clin Immunol; 1996 Jun; 97(6):1426-7. PubMed ID: 8648046
[No Abstract] [Full Text] [Related]
9. Chronic desensitization to quinolones in fixed drug eruption.
García Rodríguez R; Galindo Bonilla PA; Feo Brito FJ; Gómez Torrijos E; Borja Segade J; Lara de la Rosa P; Castro Jiménez A
J Investig Allergol Clin Immunol; 2011; 21(1):76-7. PubMed ID: 21370729
[No Abstract] [Full Text] [Related]
10. [Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].
Sollich V; Klöditz E; Schuster R; Handrick W; Brömme S; Rumler W; Patsch R; Kharari H; Spencker FB
Kinderarztl Prax; 1993 Aug; 61(6):211-4. PubMed ID: 8411847
[TBL] [Abstract][Full Text] [Related]
11. Rapid desensitization for non-immediate reactions in patients with cystic fibrosis.
Whitaker P; Shaw N; Gooi J; Etherington C; Conway S; Peckham D
J Cyst Fibros; 2011 Jul; 10(4):282-5. PubMed ID: 21388896
[TBL] [Abstract][Full Text] [Related]
12. [Ciprofloxacin: an alternative oral treatment in respiratory Pseudomonas infection in cystic fibrosis].
Magni A; Pradal U; Cazzola G; Mastella G
Pediatr Med Chir; 1990; 12(5):531-4. PubMed ID: 2087426
[TBL] [Abstract][Full Text] [Related]
13. Desensitization to pancreatic enzyme intolerance in a child with cystic fibrosis.
Chamarthy LM; Reinstein LJ; Schnapf B; Good RA; Bahna SL
Pediatrics; 1998 Jul; 102(1):e13. PubMed ID: 9651465
[TBL] [Abstract][Full Text] [Related]
14. Acute desensitization of a patient with cystic fibrosis allergic to both beta-lactam and aminoglycoside antibiotics.
Earl HS; Sullivan TJ
J Allergy Clin Immunol; 1987 Mar; 79(3):477-83. PubMed ID: 3819228
[TBL] [Abstract][Full Text] [Related]
15. Oral ciprofloxacin in the treatment of pseudomonas exacerbations of paediatric cystic fibrosis: clinical efficacy and safety evaluation using magnetic resonance image scanning.
Redmond A; Sweeney L; MacFarland M; Mitchell M; Daggett S; Kubin R
J Int Med Res; 1998 Dec; 26(6):304-12. PubMed ID: 10399112
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin-induced phototoxicity in an adult cystic fibrosis population.
Tolland JP; Murphy BP; Boyle J; Hall V; McKenna KE; Elborn JS
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):258-60. PubMed ID: 22971191
[TBL] [Abstract][Full Text] [Related]
17. Successful meropenem desensitization in a patient with cystic fibrosis.
Wilson DL; Owens RC; Zuckerman JB
Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
[TBL] [Abstract][Full Text] [Related]
18. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study.
Stass H; Weimann B; Nagelschmitz J; Rolinck-Werninghaus C; Staab D
Clin Ther; 2013 Oct; 35(10):1571-81. PubMed ID: 24054830
[TBL] [Abstract][Full Text] [Related]
19. Safety of ciprofloxacin in children with cystic fibrosis.
Orenstein DM; Pattishall EN; Noyes BE; Kurland G; Hartigan ER; Yu VL
Clin Pediatr (Phila); 1993 Aug; 32(8):504-6. PubMed ID: 8403750
[No Abstract] [Full Text] [Related]
20. [Desensitization in drug hypersensitivity].
Piotrowicz-Wójcik K; Porebski G; Czarnobilska E
Przegl Lek; 2013; 70(12):1008-10. PubMed ID: 24720117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
